Natco Pharma net profit increases 59 percent to Rs 668 crore in Q1
Hyderabad: Hyderabad-based NATCO Pharma Limited has recorded consolidated total revenue of Rs 1410.70 Crore for the first quarter ended on 30th June 2024, as against Rs 1160.2 Crore for the same period last year, reflecting a growth of 21.6 percent in revenue.
The net profit for the period, on a consolidated basis, was Rs 668.50 Crores as against Rs 420.3 Crore same period last year, showing 59 percent growth in profits. The growth in revenue and profits were driven primarily by exports formulation business.
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd